Current Pharmaceutical Design, Volume 14 - Number 15

Editorial [Hot Topic: Regulation of Brain Functions by Adenosine A2A Receptors:Implication for Therapeutics (Executive Editor: Patrizia Popoli) ]

, 14(15): 1466 - 1467

Patrizia Popoli

DOI: 10.2174/138161208784480135

An Update on Adenosine A2A-Dopamine D2 Receptor Interactions: Implications for the Function of G Protein-Coupled Receptors

, 14(15): 1468 - 1474

S. Ferre, C. Quiroz, A. S. Woods, R. Cunha, P. Popoli, F. Ciruela, C. Lluis, R. Franco, K. Azdad and S. N. Schiffmann

DOI: 10.2174/138161208784480108

Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions

, 14(15): 1475 - 1489

N. Simola, M. Morelli and A. Pinna

DOI: 10.2174/138161208784480072

Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A Receptors

, 14(15): 1490 - 1499

Jiang-Fan Chen and Felicita Pedata

DOI: 10.2174/138161208784480126

A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease

, 14(15): 1500 - 1511

Patrizia Popoli, David Blum, Maria Rosaria Domenici, Sylvie Burnouf and Yijuang Chern

DOI: 10.2174/138161208784480117

Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders

, 14(15): 1512 - 1524

Rodrigo A. Cunha, Sergi Ferre, Jean-Marie Vaugeois and Jiang-Fan Chen

DOI: 10.2174/138161208784480090

A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists

, 14(15): 1525 - 1552

G. Cristalli, C. Lambertucci, G. Marucci, R. Volpini and D. Dal Ben

DOI: 10.2174/138161208784480081

Webmaster Contact:
Copyright © 2018 Bentham Science